$RLYB
Rallybio Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$17.14
▼-0.12%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRallybio Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RLYB up today? It is at $17.14 (+0.00%). See the catalyst behind the move, real-time alerts the moment RLYB spikes, and full due diligence on RLYB — key stats, earnings, dilution and insider activity. Free.
Be first to know when $RLYB makes an unusual move. Create a free account to track $RLYB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RLYB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RLYB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMerger / acquisition agreementPrice $0.0001/share, from an SEC filing. Read it →Latest filingS-4/AS-4/a no. 2Sep 15, 2026 · 2 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Boudreau Helen M Director | Other | 4K 0.07% of company | added 100% | 7K | $8K at $2.38 | Jul 6, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +10K 0.2% of company | added 1.1% | 926K | $141K at $13.80 | May 19, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +6K 0.1% of company | added 0.7% | 916K | $84K at $13.98 | May 18, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +300 | added <0.1% | 910K | $4K at $13.80 | May 15, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +79K 1.5% of company | added 9.5% | 910K | $1.1M at $13.80 | May 13, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +800 0.02% of company | added <0.1% | 831K | $11K at $13.83 | May 12, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +50K 0.9% of company | added 6.4% | 830K | $700K at $14.00 | May 11, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +35K 0.7% of company | added 4.7% | 780K | $491K at $14.00 | May 5, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +121K 2.3% of company | added 19% | 745K | $1.7M at $13.90 | May 4, 26 |
Lieber Jonathan I Officer | Sold (automatic/other) | -789 0.01% of company | sold 16% | 4K | $4K at $5.06 | Feb 23, 26 |
Lieber Jonathan I Officer | Acquired (grant/award) | +3K 0.05% of company | added 100% | 5K | n/a | Feb 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RLYB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RLYB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RLYB last traded at $17.14, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Rallybio Corporation Common Stock (RLYB) is next expected to report earnings on Thursday, November 5, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RLYB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RLYB 0 times in the last 30 days.
RLYB (Rallybio Corporation Common Stock) trades on XNAS, with a market cap of about $91M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RLYB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RLYB discussion
Sign in to ask a question or join the discussion.